Affordable Access

Access to the full text

Regulation of the Expression of DAPK1 by SUMO Pathway

Authors
  • Wang, Qingshui1
  • Zhang, Xiuli1
  • Chen, Ling1
  • Weng, Shuyun1
  • Xia, Yun1
  • Ye, Yan1
  • Li, Ke1
  • Liao, Ziqiang1
  • Chen, Pengchen1
  • Alsamman, Khaldoon
  • Meng, Chen1
  • Stevens, Craig
  • Hupp, Ted R.
  • Lin, Yao1
  • 1 (C.M.)
Type
Published Article
Journal
Biomolecules
Publisher
MDPI AG
Publication Date
Apr 17, 2019
Volume
9
Issue
4
Identifiers
DOI: 10.3390/biom9040151
PMID: 30999631
PMCID: PMC6523460
Source
PubMed Central
Keywords
License
Green

Abstract

Death Associated Protein Kinase 1 (DAPK1) is an important signaling kinase mediating the biological effect of multiple natural biomolecules such as IFN-γ, TNF-α, curcumin, etc. DAPK1 is degraded through both ubiquitin-proteasomal and lysosomal degradation pathways. To investigate the crosstalk between these two DAPK1 degradation pathways, we carried out a screen using a set of ubiquitin E2 siRNAs at the presence of Tuberous Sclerous 2 (TSC2) and identified that the small ubiquitin-like molecule (SUMO) pathway is able to regulate the protein levels of DAPK1. Inhibition of the SUMO pathway enhanced DAPK1 protein levels and the minimum domain of DAPK1 protein required for this regulation is the kinase domain, suggesting that the SUMO pathway regulates DAPK1 protein levels independent of TSC2. Suppression of the SUMO pathway did not enhance DAPK1 protein stability. In addition, mutation of the potential SUMO conjugation sites on DAPK1 kinase domain did not alter its protein stability or response to SUMO pathway inhibition. These data suggested that the SUMO pathway does not regulate DAPK1 protein degradation. The exact molecular mechanism underlying this regulation is yet to be discovered.

Report this publication

Statistics

Seen <100 times